This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 1 July 2003, pp. 191-192

POLICY STATEMENT

Controversies Concerning Vitamin K and the Newborn

Committee on Fetus and Newborn

Prevention of early vitamin K deficiency bleeding (VKDB) of the newborn, with onset at birth to 2 weeks of age (formerly known as classic hemorrhagic disease of the newborn), by oral or parenteral administration of vitamin K is accepted practice. In contrast, late VKDB, with onset from 2 to 12 weeks of age, is most effectively prevented by parenteral administration of vitamin K. Earlier concern regarding a possible causal association between parenteral vitamin K and childhood cancer has not been substantiated. This revised statement presents updated recommendations for the use of vitamin K in the prevention of early and late VKDB.

Abbreviations: VKDB, vitamin K deficiency bleeding


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Statements of reaffirmation:

AAP Publications Reaffirmed, May 2006

Pediatrics 118: 1266-1266. [Full Text]

Policy Statement--AAP Publications Retired and Reaffirmed
Pediatrics 124: 845-845. [Full Text]

The following policy statement has been revised:

Controversies Concerning Vitamin K and the Newborn

Pediatrics 91: 1001-1002.



This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
A. Busfield, A. McNinch, and J. Tripp
Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness
Arch. Dis. Child., September 1, 2007; 92(9): 754 - 758.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. Clarke, S. J. Mitchell, R. Wynn, S. Sundaram, V. Speed, E. Gardener, D. Roeves, and M. J. Shearer
Vitamin K Prophylaxis for Preterm Infants: A Randomized, Controlled Trial of 3 Regimens
Pediatrics, December 1, 2006; 118(6): e1657 - e1666.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Section on Breastfeeding
Breastfeeding and the Use of Human Milk
Pediatrics, February 1, 2005; 115(2): 496 - 506.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. T. Costakos, M. Porte, C. A. Miller, L. R. Blackmon, and On behalf of the Committee on Fetus and Newborn
Did "Controversies Concerning Vitamin K and the Newborn" Cover All the Controversies?
Pediatrics, May 1, 2004; 113(5): 1466 - 1467.
[Full Text] [PDF]